Latest / Pharmacy Podcast Network / Thug Drugs: GABA, GABA, GABA | Pain Pod
Transcript
- 0:06Speaker 1: You are listening to the Pharmacy Podcast Network. This is
- 0:18Speaker 1: the Pain Pod. You want to see pain.
- 0:21Speaker 2: Look at me? Welcome to the Pain Pod, the podcast
- 0:32Speaker 2: for all things pain management, hosted by the Pain Guy,
- 0:37Speaker 2: doctor Mark gro We'll be collaborating with numerous pain management experts,
- 0:46Speaker 2: talking about substance usage disorders, the latest treatment modalities, and
- 0:51Speaker 2: most important important focusing on the pain of our patients
- 0:55Speaker 2: as leading providers of pain care. And now here's our host,
- 1:02Speaker 2: a man wanted in all fifty states, a suburban city
- 1:07Speaker 2: like Mountain Man without the beard, from the hills of
- 1:11Speaker 2: West Virginia and certified in weapons of mass destruction response Yese.
- 1:20Speaker 1: Doctor Mark Slaboy. All right, welcome back, folks to the
- 1:28Speaker 1: Pain Pod. Oh our intros kind of get you going right. Well,
- 1:32Speaker 1: we have a special treat today. We're gonna dive back
- 1:36Speaker 1: into our I guess I'll call it our mini series
- 1:40Speaker 1: thug drugs. Yeah, those things that are outside of the
- 1:43Speaker 1: healthcare supply chain, but sometimes you know, kind of make
- 1:47Speaker 1: their way into it or come from it as well too.
- 1:50Speaker 1: I believe we call that diversion on one of those
- 1:52Speaker 1: streets anyway. But here in our little mini series of
- 1:56Speaker 1: thug drugs. Here on the Pain Pod today, we're gonna
- 1:59Speaker 1: be going over thug drugs. Gabba, So, gabba, gabba gabba.
- 2:03Speaker 1: What's it all about? Right? Well, let me just start
- 2:08Speaker 1: out with where can we find this infamous gaba? Right? So,
- 2:13Speaker 1: it's you know, certainly something that's within our nervous system overall,
- 2:18Speaker 1: and also naturally occurring you know, out there in nature.
- 2:22Speaker 1: It's found in different plants. It's actually here comes a
- 2:26Speaker 1: fun science fact, right, it's the most abundant amino acid
- 2:30Speaker 1: in the able plast that's the plasma near the cell
- 2:33Speaker 1: wall rocking out our freshman year, right of tomatoes or tomatoes,
- 2:38Speaker 1: however you go about it. Right, So is this whole
- 2:41Speaker 1: thug drugs episode on tomatoes today? Well, it's all about
- 2:45Speaker 1: the dosage baby, right? Not quite but yes, oh we
- 2:49Speaker 1: sound confused. Let's dive a little deeper into what's all
- 2:52Speaker 1: about this gabba? Right? So, gaba gaba gabba. Where where
- 2:55Speaker 1: is that? You know? Where is its exhibiting in its action? There?
- 2:57Speaker 1: You know. Neural transmitters are like the little post it notes,
- 3:01Speaker 1: the notes that elementary school students might pass to each other.
- 3:05Speaker 1: I know, I know there's electronics these days, but turns
- 3:08Speaker 1: out most schools don't allow them anyway, So you got
- 3:10Speaker 1: to go old school with the post it notes, and
- 3:12Speaker 1: our bodies do that with neurotransmitters. So if you've got
- 3:15Speaker 1: one kid in a class passed a note to another
- 3:17Speaker 1: kid in the class, what we're talking about there is
- 3:19Speaker 1: the synaptic left. When we're going into the nervous system,
- 3:22Speaker 1: you've got the first neuron and you've got the second neuron.
- 3:27Speaker 1: They communicate with neurotransmitters. There we're talking about at least today, gabba, right, Gabba,
- 3:33Speaker 1: Gabba gabba. So there's certain you know, gabba pentanoids say
- 3:38Speaker 1: that one eh, even once, right, particularly for our folks,
- 3:42Speaker 1: our listeners outside of healthcare. Yeah, we like to complicate
- 3:45Speaker 1: the words. I don't know if it's job security or
- 3:47Speaker 1: if it's absolutely necessary, but well here today we're gonna
- 3:50Speaker 1: be saying gabba pentanoids a lot, right, So that's Gabba
- 3:53Speaker 1: related substances. You know, we have medications you know, legal
- 3:58Speaker 1: for prescribing, dispensing, so and so forth, and we have
- 4:01Speaker 1: stuff that's hit in the streets all cross the globe,
- 4:03Speaker 1: by the way, But back to those neurons one and two.
- 4:05Speaker 1: With neuro tradamitsminners in between the old snaptic cleft, right,
- 4:09Speaker 1: So the pre synaptic neuron that's the first one. You
- 4:12Speaker 1: got some calcium channels there that certain gaba pentinoids like
- 4:16Speaker 1: gaba pentin and preabalin you know, utilizing well a lot
- 4:20Speaker 1: of different medical conditions these days. And then you know
- 4:24Speaker 1: that's going to affect gabba release and then post snaptically
- 4:28Speaker 1: or neuron number two on the bottom of the right,
- 4:30Speaker 1: depending on where your mind's going. That's where we see
- 4:33Speaker 1: a lot of mechanisms of medications and drugs alike, things
- 4:38Speaker 1: like benzos, barbituits, you name it, right. So in this
- 4:42Speaker 1: overall neural one, neuron two, pre synaptic, post snaptic in
- 4:45Speaker 1: the cleft in between, that's the Bullparkkay. In that ballpark,
- 4:49Speaker 1: there's a lot of different medications and substances that exhibit
- 4:53Speaker 1: their action. Alcohol is there, A lot of seizure medications
- 4:56Speaker 1: are there. The list goes on, right, but it all
- 4:59Speaker 1: comes down to that gabba release. Gabba is there to
- 5:03Speaker 1: inhibit the neuroprocessing, to slow things down. So here's where
- 5:08Speaker 1: it gets tricky. All those straightforward oh man, my seventh
- 5:12Speaker 1: grade English teacher would be oh, I wouldn't be happy
- 5:15Speaker 1: with this episode because we're gonna use a double negative.
- 5:17Speaker 1: That's pretty much all the Gabba pentanoids and Gabba related substances, okay,
- 5:21Speaker 1: because Gabba is an inhibitor. So if you inhibit an inhibitor,
- 5:25Speaker 1: you get you know, more of the positive, right, But
- 5:30Speaker 1: if you enhance an inhibitor, Oh, that's pretty straightforward, you
- 5:33Speaker 1: get more inhibition. Right, Have I lost you yet? I
- 5:37Speaker 1: just think of those elementary school teachers that are worried
- 5:40Speaker 1: about double negatives, and quite frankly us in academian universities
- 5:43Speaker 1: across the globe too. Right. So Gabba is an inhibitor,
- 5:46Speaker 1: we want to remember that. Okay, that's the background. Let's
- 5:50Speaker 1: actually jump into what the heck we're gonna be talking
- 5:52Speaker 1: about here today. So our Gabba related substances, we have
- 5:56Speaker 1: things like methic alone. Finebut GHB, arbituits, gabapentinoids, and benzodesepines
- 6:04Speaker 1: benzos rounding out the pack. Right, So let's go to
- 6:07Speaker 1: Let's go to quayludes first with meta Quaelon. So that
- 6:11Speaker 1: actually was a you know, a prescription name back in
- 6:17Speaker 1: the day when it first came out. The Quaylude came
- 6:19Speaker 1: from a quiet interlude, the qu and the lude. That's
- 6:24Speaker 1: where we get quaylude from the name, right. Lots of
- 6:27Speaker 1: other streets slang of ludes, soaps, mandrakes, mandies, think back
- 6:33Speaker 1: to the mandrake root for that mandrakes thing covered that
- 6:37Speaker 1: the Hallucinogens thug drug mini series here in the pain
- 6:39Speaker 1: Pod also lemons along the way as well too, So
- 6:43Speaker 1: albout some history here. So it was first synthesized over
- 6:46Speaker 1: in India as an anti malarial medication or aiming for that,
- 6:51Speaker 1: back in nineteen fifty one. About a decade later, was
- 6:54Speaker 1: patented here in the US. Didn't take too long, right,
- 6:57Speaker 1: added an antihistamine to that over in Europe and that
- 7:02Speaker 1: was run in the sixties. Then we got the name
- 7:07Speaker 1: change to Mechuin in the seventies. Nineteen seventy three, specifically
- 7:11Speaker 1: it was designated by the DEA's Controlled Substance Class two.
- 7:16Speaker 1: Nine years later in eighty two it was withdrawn from
- 7:18Speaker 1: our market, and in nineteen eighty four it was made
- 7:20Speaker 1: a Controlled Substance Class one. So it's had a roller
- 7:23Speaker 1: coaster ride pretty much all downhill though right where we
- 7:26Speaker 1: see this across the globe though, so South Africa, Okay,
- 7:30Speaker 1: The products are typically made in India and they're observed
- 7:33Speaker 1: to be a common substance of abuse in South Africa, right,
- 7:37Speaker 1: the country at the southernmost tip of Africa. All Right,
- 7:42Speaker 1: so you know how does it work, well, quailudes, I'll
- 7:45Speaker 1: go with that name. They increase gaba activity, so they're
- 7:48Speaker 1: doing more gab activity, so more inhibition of those neural processes. Right.
- 7:54Speaker 1: So there's as far as abuse, there's a terming known
- 7:57Speaker 1: as looting out when it's combined with alcohol. Also if
- 8:01Speaker 1: the tablets are crushed and smoked with cannabis or tobacco
- 8:04Speaker 1: your choice, and a broken off bottleneck. Yeah, very specific,
- 8:09Speaker 1: but this is what's out there right that's called white pipe.
- 8:12Speaker 1: The things we come up with right now. You may
- 8:15Speaker 1: remember coeludes or metha quaelon from relatively more recent when
- 8:19Speaker 1: we had a celebrity that got into some legal scenarios
- 8:25Speaker 1: with that. That was of course Bill Cosby. You know
- 8:27Speaker 1: the updates of that case where that things didn't proceed
- 8:30Speaker 1: as they're supposed to do and the legal end so
- 8:34Speaker 1: you know, it went down different route there. But that's
- 8:36Speaker 1: where we've probably most likely heard of couayludes recently. All Right,
- 8:41Speaker 1: let's jump to our next GABA related substance here, FINNEBT.
- 8:46Speaker 1: So it's available in very supplements. What is it, Well,
- 8:50Speaker 1: it's a GABBA structural analog, so it's kind of like GABBA, right,
- 8:55Speaker 1: you're going to get that inhibition within the nerves the
- 8:59Speaker 1: nervous system, right, because it's a GABBA be specifically agonist
- 9:03Speaker 1: to get really specific there, but it can also be
- 9:06Speaker 1: known as a nootropic. So that's said to be something
- 9:09Speaker 1: that would be cognition enhancing along the way. Right, So
- 9:14Speaker 1: how about some let's get some nerdy medcham going on here.
- 9:17Speaker 1: So it's fenyl amino butic acid. Yeah, like you wanted
- 9:23Speaker 1: to hear that on the podcast, right, You know, it
- 9:26Speaker 1: matters of that Fennel group, the little ring that Fennel
- 9:29Speaker 1: group added onto what would be GABBA. Basically that that addition,
- 9:33Speaker 1: that structural addition allows to cross the old BBB, the
- 9:36Speaker 1: blood brain barrier, and that's obviously, of course, very important
- 9:40Speaker 1: because you get more effect more profound once you're within
- 9:44Speaker 1: the CNS within the brain specifically of course. So FEDIB
- 9:49Speaker 1: we kind of you know, some origins here. What we're
- 9:52Speaker 1: talking about in the big picture would be back in
- 9:54Speaker 1: the USSR today we'd say Russia of course, but you know,
- 9:58Speaker 1: across the globe, Australian and Hungary they actually aim to
- 10:01Speaker 1: control access of this unlike most other places. But Russia, Ukraine,
- 10:06Speaker 1: lot Via they actually utilized this substance as a prescription
- 10:10Speaker 1: medication to utilize for anxiety and sleep overall tablets and
- 10:15Speaker 1: solution available. So you know, it's something to be aware
- 10:18Speaker 1: of because well, first off, folks travel, Okay, I recently
- 10:21Speaker 1: talked to some international travelers and they were blown away
- 10:23Speaker 1: of how you know, the things they have to keep
- 10:25Speaker 1: in mind when traveling country or continent to continent, when
- 10:29Speaker 1: going through things like TSA or you know whatever service
- 10:32Speaker 1: there is across the globe. So big picture things, all right,
- 10:37Speaker 1: Let's jump to our next heavy hitter here today, GHB.
- 10:42Speaker 1: A lot of folks are aware of this. Of course,
- 10:44Speaker 1: slang terms like date rape drug of course, just one
- 10:47Speaker 1: of them. But you know one that gets the title
- 10:50Speaker 1: liquid E, liquid x S, lollypops, you name it. How
- 10:53Speaker 1: does it work? It's a gabba B for beta agonist again,
- 10:57Speaker 1: so again we're getting that Gabba action of in inhibition
- 11:00Speaker 1: with with the neurons, right, So you know, going to
- 11:05Speaker 1: the MEDCAM or CAM in general. Here, GHP actually is
- 11:09Speaker 1: a natural occurring neural transmitter, but again it's all about
- 11:13Speaker 1: how much within the you know, the body overall. GHB
- 11:17Speaker 1: is actually a precursor to GABBA. So that's where we
- 11:19Speaker 1: get some of that action phoned uh kind of naturally,
- 11:22Speaker 1: I guess we'll say beer wine, citrus fruits. That's where
- 11:25Speaker 1: that natural stuff occurs there, uh, usually formed within the
- 11:29Speaker 1: fermentation process along the way as well. So you know,
- 11:34Speaker 1: we have the crossroads here. There's medicinal products and then
- 11:37Speaker 1: there's you know, the the other side of the coin,
- 11:40Speaker 1: on the illicit side. So we have sodium oxibate and
- 11:43Speaker 1: potassium oxibate is the two products that are available for
- 11:46Speaker 1: medicinal use, which, by the way, what's you know, what's
- 11:50Speaker 1: the use as well, cataplexy with narcolepsy, excessive daytime sleeping
- 11:54Speaker 1: or eds. I've actually, I'm sure others have seen observations
- 11:59Speaker 1: that really rare. But utilization for alcohol use disorder as
- 12:02Speaker 1: well too kind of a stretch, but there are reports
- 12:04Speaker 1: out there. Of course. GHB onset's usually fifteen minutes to
- 12:09Speaker 1: an hour, probably that fifteen minute side duration up to
- 12:11Speaker 1: six hours maybe a little less, but you know within
- 12:14Speaker 1: the realm there as well too. So interestingly, urin drug
- 12:17Speaker 1: monitory can only detect it within hours of ingestion, soit's
- 12:20Speaker 1: been like a day later than or kind of up
- 12:22Speaker 1: a creek there, not the year inside of it all too.
- 12:25Speaker 1: So all right, so GHB, where's it been? Where's it going?
- 12:30Speaker 1: Got to go back pretty far. It was eighteen seventy
- 12:33Speaker 1: four when the first articles were published when it came
- 12:37Speaker 1: to GHB overall, and you know, fast forward about almost
- 12:42Speaker 1: a century back in the sixties. Nineteen sixties Europe Act
- 12:45Speaker 1: would utilize it as an anesthetic, but then learned by
- 12:48Speaker 1: observation that it caused seizures, So that'll get you right.
- 12:52Speaker 1: In nineteen ninety early on Roam May it was actually
- 12:56Speaker 1: marketed as a dietary supplement, so go figure with that.
- 13:01Speaker 1: It had to do with l Trip to Fan being
- 13:03Speaker 1: removed from the market the year prior, so there's a
- 13:05Speaker 1: lot going on there. But anyways, the couple about six
- 13:11Speaker 1: months later that was kind of switched where the you know,
- 13:13Speaker 1: the FDA was warning that GHB sale was illegal. That
- 13:18Speaker 1: being said that you can continuing out in the nineteen nineties,
- 13:21Speaker 1: GHB sales continued, I actually became a club drug, and
- 13:24Speaker 1: of course the date rape drug one of but typically
- 13:27Speaker 1: the title one. In two thousand it became a controlled
- 13:31Speaker 1: subsens class one. However, sodium oxibate is a controlled substance
- 13:36Speaker 1: Class three with Controlled Substance Class one trafficking penalties. You know,
- 13:41Speaker 1: we navigate when the whole realm of thlug drugs. We
- 13:43Speaker 1: navigate the classification of controlled substances all the time. This
- 13:47Speaker 1: is actually an interesting one too, right, So there's actually,
- 13:52Speaker 1: I guess, on the brighter side, a newer synthetic drug
- 13:54Speaker 1: it's named s H five zero nine to one one
- 13:58Speaker 1: that actually quickly reverses GHB overdose, and it was found
- 14:02Speaker 1: to do so in mice. Anyway, that being said, it's
- 14:05Speaker 1: gonna be pretty tricky to have, you know, more studies
- 14:08Speaker 1: because the whole CS one classification aka illegal. Right, all right,
- 14:13Speaker 1: enough about GHB for now, let's go into the barbs.
- 14:16Speaker 1: Let's go to barbituates. You know, for US healthcare professionals
- 14:20Speaker 1: listening in and chatting here, we get lost in the
- 14:24Speaker 1: shuffle sometimes of you know, which which barbituates are actually available,
- 14:29Speaker 1: what controlled substance class are they? And then you might
- 14:32Speaker 1: as well, add in, hey, what are they called in
- 14:33Speaker 1: the streets too? So I cant run through maybe a
- 14:35Speaker 1: half dozen or so here, but amal barbital is a
- 14:39Speaker 1: C two. But if it's in a combination of the
- 14:41Speaker 1: positories to C three, yeah, guess confusing right, commonly referred
- 14:46Speaker 1: to as blues or blue heavens. Let's like a barbital
- 14:51Speaker 1: is a CS one, known as rainbows or Christmas trees
- 14:54Speaker 1: of all things. But albaital CS three sometimes not even
- 15:00Speaker 1: available though. Got panta barbital you know, also C two
- 15:06Speaker 1: or C three and combour suppository that's yellows piena barbital
- 15:10Speaker 1: most commonly known, that's a CS four. So it's a
- 15:12Speaker 1: big difference there, streets lying at pink ladies, siko barbitall
- 15:16Speaker 1: same thing with that C two solo, and then if
- 15:19Speaker 1: it's combined with other ingredients or in a suppository to
- 15:22Speaker 1: CS three, those are known as reds. So basically we've
- 15:25Speaker 1: got the whole spectrum of the rainbow almost not quite roygbiv,
- 15:29Speaker 1: but the slang terms are often colors or even rainbow
- 15:33Speaker 1: in general. Okay, so what about Barbitriit's in the big picture.
- 15:37Speaker 1: So back in the early nineteen hundreds. This is even
- 15:40Speaker 1: before benzos. It was when they were first introduced for
- 15:43Speaker 1: medical use. How do they work well? Barbituates are right
- 15:47Speaker 1: in that ballpark as far as this snaptic cleft around
- 15:50Speaker 1: one in neuron two. They enhance the gab activity at
- 15:53Speaker 1: the GABA receptor that's post snaptically the second neuron. Barbituits
- 15:58Speaker 1: have a very narrow therapeutic d The difference between one
- 16:01Speaker 1: to help you and what will kill you so very
- 16:03Speaker 1: important dose and considerations. In fact, abrupt discontinuation can lead
- 16:08Speaker 1: to life threatening withdrawal. We see this even just like
- 16:11Speaker 1: with benzos, with seizure risk along the way as well too.
- 16:13Speaker 1: So all right, here's a little easter egg for us. Okay,
- 16:18Speaker 1: fur a set and fur and all from my prescribers
- 16:21Speaker 1: and dispenser's out there. Where do we go with this?
- 16:23Speaker 1: What's all the confusion with what's the controlled substance? What's
- 16:26Speaker 1: not right? So fear a set that's a cedamnifin, betabodol
- 16:31Speaker 1: and caffeine. Right, there's an old formulation. It had three
- 16:34Speaker 1: hundred and twenty five miligrams of aceta menifin fifty miligrams
- 16:38Speaker 1: betabodol forty miiligrams caffeine. The newer formulation changed the aceeta
- 16:42Speaker 1: menifin from three hundred and twenty five miligrams to three
- 16:44Speaker 1: hundred whoa huge change, right, twenty five whopping milgrams of
- 16:48Speaker 1: a ceta menifin. Oh, it makes me think about when
- 16:51Speaker 1: I heard a healthcare practitioner one time explained to a patient, Sir,
- 16:55Speaker 1: you don't understand how well this medication is going to work.
- 16:57Speaker 1: It is five one hundred millions of acetamnifin. I think
- 17:03Speaker 1: I think my pupils even got a little bit larger
- 17:05Speaker 1: because I was like, Wow, this explanation is actually working.
- 17:08Speaker 1: I digress anyways, you know, fear set it is not
- 17:12Speaker 1: a federal controlled substance. Why because of the ratio of
- 17:15Speaker 1: the acidamnifin to the buttabataal if Basically, there's more than
- 17:21Speaker 1: seventy milligrams of aceta minifin for every fifteen milligrams of
- 17:25Speaker 1: thetalbatal well formulation new formulation, so it's not a federal
- 17:28Speaker 1: controlled substance. Alas, states can be different. In fact, Georgia, Illinois, Maryland,
- 17:36Speaker 1: New Mexico, Rhode Island, Utah, and my own Wild and
- 17:39Speaker 1: Wonderful West Virginia. All seven of those states classified as
- 17:43Speaker 1: a controlled substance Class three. Yeah, it's fun. Whereas fear
- 17:48Speaker 1: and All, which is basically the same thing via substitute
- 17:50Speaker 1: three hundred and twenty five miligrams of aspirin for the
- 17:53Speaker 1: acetam menifin. That's a controlled substance Class three federally. Okay,
- 17:58Speaker 1: I hope this helps all folks, my pharmacists out there.
- 18:01Speaker 1: Oh my goodness, we're the only healthcare profession with the LOGXAM.
- 18:05Speaker 1: Good or bad. Hey, that's a conversation for another day. Right, Well,
- 18:08Speaker 1: we're tied directly into product too, but we need to
- 18:10Speaker 1: know this stuff. This question is literally on d MPJE.
- 18:13Speaker 1: You're welcome also know the poison center when I on
- 18:16Speaker 1: at all two is with a one in the middle.
- 18:17Speaker 1: Right there, you got like two questions already done for
- 18:19Speaker 1: the pharmacy LOGXAM. There we go. But big picture of
- 18:23Speaker 1: you're a set not federally controlled. Seven states have it
- 18:25Speaker 1: as a CS three. Far and All is a federal
- 18:27Speaker 1: controlled substance Class three. That's that boom boom, boom, hands
- 18:31Speaker 1: away right all right, now that we're diving deeper into
- 18:34Speaker 1: the healthcare side of things, let's go into general Gabba pentenoids.
- 18:38Speaker 1: First one I going to mention is backlifin. I go
- 18:40Speaker 1: into that a little bit more in our pain Pod
- 18:42Speaker 1: episode talking about muscle relaxes. So I kind of lay
- 18:45Speaker 1: low on that today because backliffin is a structural analog
- 18:48Speaker 1: of gabba. So you're going to get that inhibition with
- 18:51Speaker 1: the nerves. Okay, But here we're really you know, want
- 18:54Speaker 1: to talk about Gaba penton and pre gabbling. Right, So
- 18:57Speaker 1: gabbat penton adds a cycle hexel group, a little amical
- 19:00Speaker 1: group onto gabba and there, Yeah, that's where we see it.
- 19:05Speaker 1: Pretty Gamblin however's relatively more potent than gabapentin, has a
- 19:09Speaker 1: faster on set about a day as compared to gabapentin
- 19:14Speaker 1: generally speaking. Anyway, now we did the whole fear set
- 19:18Speaker 1: FORAR and all thing. So gabapentin is not a federal
- 19:21Speaker 1: controlled substance you know, as oc current time anyway, and
- 19:25Speaker 1: certainly not going to see that necessarily in the future
- 19:28Speaker 1: changing because that probably would have happened a while ago. Right,
- 19:31Speaker 1: But there are seven states that have gabapentin as a
- 19:34Speaker 1: controlled substance status. We've got Virginia, West Virginia, Remember, folks,
- 19:39Speaker 1: that's two different states, right, good gully, Kentucky, Tennessee, Alabama,
- 19:44Speaker 1: and then we kind of jump out of Appalachian, say,
- 19:46Speaker 1: Michigan and North Dakota out of the blue right. So love,
- 19:49Speaker 1: seven states already have it as a controlled substance. You know,
- 19:53Speaker 1: when you look at the mechanism, if you're being objective,
- 19:55Speaker 1: it's like, why wouldn't it be a controlled substance. It's
- 19:57Speaker 1: in the same ballpark, it's in the same synaptic left
- 19:59Speaker 1: as the other controlled substances. So what's so special about
- 20:02Speaker 1: this poppy? Right? Well, that's I guess the point of
- 20:04Speaker 1: view of those seven states right there. All right, So
- 20:07Speaker 1: further with gabapentin. As far as dosing, the maximum adult
- 20:10Speaker 1: dose is thirty six hard milgrams in the day. Sounds
- 20:13Speaker 1: like a loppy you get there quick. Gama patent is
- 20:15Speaker 1: pretty much for one of the poster kiddos for start low,
- 20:18Speaker 1: go slow dosing. Okay, The easiest way to lose this
- 20:21Speaker 1: option for any patient is to start with a higher
- 20:24Speaker 1: dose or to ty trate increase the dose too quickly,
- 20:28Speaker 1: because then you get side effects and then folks are
- 20:29Speaker 1: gonna be like, I never want to try that. Again,
- 20:31Speaker 1: and that's just because we didn't go with the start low,
- 20:34Speaker 1: go slow dosing really important. Overall, it's available in immediate release,
- 20:39Speaker 1: Extended release tablets also a solution along the way as
- 20:42Speaker 1: well too, So you know, one of the things in
- 20:46Speaker 1: relatively recent years, I think GAMA patent related overdose deaths
- 20:50Speaker 1: have started to be tracked. So first off, I want
- 20:53Speaker 1: to say, you know, like what's up with that? Well,
- 20:55Speaker 1: when you you know, when you put the stranglehold on
- 20:57Speaker 1: things like opioids, then other things are going who come
- 21:00Speaker 1: to the rescue to help patients in pain, right, and
- 21:03Speaker 1: hopefully they're within a diverse treatment plan overall armacological and
- 21:08Speaker 1: non pharmacological and lots of options within right. But if
- 21:11Speaker 1: you start tracking something, it can only go up or
- 21:14Speaker 1: remain zero. It can't go down because you're starting to
- 21:17Speaker 1: track it. So you know, like in my own state
- 21:19Speaker 1: of well, no wonder for West Virginia, gosh, like a
- 21:22Speaker 1: decade ago they started it, We started tracking that and
- 21:24Speaker 1: you know, it was like, oh, dozens of gabapet and
- 21:26Speaker 1: related overdoses right out of the gate, and then within
- 21:28Speaker 1: about five years it was like tripled. And you know
- 21:32Speaker 1: that's a trend that's something to recognize along the way,
- 21:35Speaker 1: but there was, you know, still relatively no low numbers
- 21:38Speaker 1: compared to the over one hundred thousand opioate overdose deaths.
- 21:41Speaker 1: Right and by the way, words matter related deaths doesn't
- 21:46Speaker 1: mean person takes a gabapetent tablet and dies. It's related
- 21:50Speaker 1: because it was within the system with other sedatives as well.
- 21:53Speaker 1: So we got to keep that in mind, or at
- 21:55Speaker 1: least potentially like that. Right on the other side of
- 21:58Speaker 1: the coin. Gabapetan does have, of course, the withdrawal syndrome
- 22:01Speaker 1: because it works within that ballpark with you know, the
- 22:04Speaker 1: nerve pre snaptic post snaptic neurons one and two and
- 22:08Speaker 1: the cleft in between. Uh So we got to really
- 22:10Speaker 1: you know, watch that, just like with benzos along the
- 22:12Speaker 1: way as well too, alluding to our next category, right
- 22:16Speaker 1: all right, right before we go to that, though, let's
- 22:18Speaker 1: talk about pregabling really quick. So Pregablin, or Lyric as
- 22:21Speaker 1: most folks would know it, had some action crossed the
- 22:25Speaker 1: pond over there in Britain, right once the tea party
- 22:27Speaker 1: was over, A couple hundred years went by, and all
- 22:29Speaker 1: of a sudden recent years there was a notice some
- 22:34Speaker 1: some action some availability happening with rerega or the streets
- 22:38Speaker 1: slaying for pre gambling. Right it actually border offers officers sorry,
- 22:45Speaker 1: and they they got a loaded basically that they once
- 22:49Speaker 1: found a ton of limean mango at Shutney that was
- 22:51Speaker 1: imported from India. Uh, and you know some flags went
- 22:55Speaker 1: off and when when when testing things and figuring out, well,
- 22:58Speaker 1: it turns out it was actually pregabling in there, not Chutney, right,
- 23:01Speaker 1: fancy jam, I guess right, Oh that's not our jam.
- 23:05Speaker 1: That's over in Britain though, right, all right, let's jump
- 23:08Speaker 1: back in. I was already alluding to benzos, so let's
- 23:10Speaker 1: jump into benzodis epines. Right, So long history, less than
- 23:15Speaker 1: a hundred years, but long history. The first benzo was
- 23:18Speaker 1: chloride's epoxide or librium back in nineteen fifty five. Five
- 23:23Speaker 1: years later, it was after it was identified. It was
- 23:27Speaker 1: FDA approved in nineteen sixty and then three years later
- 23:30Speaker 1: diaza pam was FDA approved. Same company, by their way
- 23:33Speaker 1: was Hoffman Laroche, and diazapam actually became the first blockbuster
- 23:37Speaker 1: medication aka best selling. The financial dollars are different today
- 23:41Speaker 1: to be a blockbuster medicine, but you know, back in
- 23:43Speaker 1: the day inflation adjusted of course. So and you know,
- 23:47Speaker 1: since then, we've had quite frankly, a plethora of different
- 23:50Speaker 1: benzo dazepines available along the way, and you know, when
- 23:54Speaker 1: wrapping our heads around it, generally speaking, we have long acting,
- 23:58Speaker 1: intermediate acting, and you guessed it short acting, right. Fun fact,
- 24:04Speaker 1: the most recent Beers criteria list, we have another episode
- 24:08Speaker 1: of the pain pod on that as well. Within pay
- 24:10Speaker 1: management realm, it used to be, oh, we'll avoid all
- 24:13Speaker 1: the benzos except for the short acting. Now it's all
- 24:15Speaker 1: of them. Okay, all of them are recommended to be
- 24:18Speaker 1: avoided for those sixty five and older. What else do
- 24:21Speaker 1: you do? Well, check out that episode. And we talked
- 24:24Speaker 1: through that a little bit more, right, But that's the
- 24:26Speaker 1: big picture. Then there's also you know that's in the
- 24:29Speaker 1: healthcare room. Then there's a ro hipmanal or flu knit
- 24:32Speaker 1: trays of PAM. I'm sure we've heard that one before.
- 24:37Speaker 1: Roofees more to come on that, right, but it's actually
- 24:40Speaker 1: said to be more than ten times more potent than
- 24:43Speaker 1: days of PAM or valuum. So you know, certainly some
- 24:46Speaker 1: considerations and things there. Now when I say roofies, I
- 24:49Speaker 1: guarantee in ninety percent? Idea? Are I thinking the Hangover movie? Right,
- 24:55Speaker 1: the age old why do they call them roofies when
- 24:57Speaker 1: you end up on the floor. I know pretty much
- 25:01Speaker 1: everybody has seen the movie, right, the whole darn movie
- 25:04Speaker 1: is talking about you know this benzo who knew right well,
- 25:08Speaker 1: we all knew it towards the end, but they would
- 25:10Speaker 1: just say roofies. They wouldn't say, you know, the actual
- 25:12Speaker 1: Benzo name. But we got to keep that in mind overall.
- 25:17Speaker 1: All right, So you know I mentioned date rape drug earlier.
- 25:21Speaker 1: You know, in this overall thug drugs, Gaba gaba gabba.
- 25:24Speaker 1: But there's actually date rape drug detectors that are out there,
- 25:28Speaker 1: you know, whether it's a napkin that goes under a beverage,
- 25:30Speaker 1: whether it's drops that go on a beverage, whether it's
- 25:32Speaker 1: a cup, and we just you know, public service announcement.
- 25:35Speaker 1: They're out there. We just have to watch because you know,
- 25:38Speaker 1: some of the more recent informations is leading towards the
- 25:42Speaker 1: idea that the products are lacking efficacy data. And if
- 25:45Speaker 1: you're wrong with that, that's a huge problem. Right. You know,
- 25:48Speaker 1: there's at least one study so that the little coasters
- 25:51Speaker 1: you put under a drink lacked reliability and specificity. That's
- 25:54Speaker 1: not going to work out. And another one, another study
- 25:57Speaker 1: found that the testers only detected two out of three
- 25:59Speaker 1: drug samples. You know, again, this is high stakes, so
- 26:03Speaker 1: it's got to beyond right. By the way, GHB also
- 26:06Speaker 1: occurs naturally in wine, So there's that along the way
- 26:09Speaker 1: as well too. If that's the beverage of choice for
- 26:10Speaker 1: an evening. All right, let's jump back into benzos, benzols,
- 26:14Speaker 1: benzos here. But you know, there's actually novel psychoactive substances.
- 26:18Speaker 1: Some of the most abundant nps is these days are benzos. Okay,
- 26:22Speaker 1: we're not thinking the ones in healthcare, we're thinking the
- 26:24Speaker 1: random others. Okay. You know, if you look back about
- 26:27Speaker 1: five years at tease, a lamb was the leader of
- 26:31Speaker 1: the pack. These days it's rome as a lamb say
- 26:36Speaker 1: either of those more than once good gully right. They're
- 26:39Speaker 1: structural analogs, you know, for instance, romans alam, which is
- 26:43Speaker 1: the current leader, the most observed NPS or benzo out there,
- 26:47Speaker 1: structurally related to al praslam or xanax. Whereas you know,
- 26:52Speaker 1: others are just along those same lines of structural analogs
- 26:55Speaker 1: along the way as well too, So you know, big picture,
- 26:59Speaker 1: weren't thinking benzos. It's a two way street. It's a
- 27:01Speaker 1: teeter totter that's very tricky. You know, you want to
- 27:04Speaker 1: avoid rapid tapers because that could lead to seizures, which
- 27:07Speaker 1: could be deadly. And you want to avoid overuse because
- 27:10Speaker 1: that can lead to respiray depression which could lead to
- 27:13Speaker 1: death as well. Too much or too little, very quickly
- 27:17Speaker 1: can lead to life threatening concerns, So we've got to
- 27:20Speaker 1: keep that in mind. Overall, there's, of course the overall idea.
- 27:23Speaker 1: You know, if you have a pulse and a healthcare
- 27:25Speaker 1: license in any state, you're well aware that benzos and
- 27:28Speaker 1: opioids have an interaction. Duh, right, it's what we do
- 27:32Speaker 1: about it. That's where the magic sauce is. I mean,
- 27:34Speaker 1: there's studies out there that would say that overdose rates
- 27:36Speaker 1: double when a benzo's added to an opioid. There's another
- 27:40Speaker 1: study that says it triples. There's another one that says
- 27:42Speaker 1: it's five x. The bottom line is the overdose risk
- 27:45Speaker 1: increases because again going back to the Gabba Bullpark, nuri
- 27:49Speaker 1: one neuron, two pre snaptic, post snaptic, they're all working
- 27:52Speaker 1: within that same realm there, right for the senative things.
- 27:56Speaker 1: So it's almost like a you know, if you have
- 27:58Speaker 1: a benzon opioid, it's like a playground find like who's
- 28:01Speaker 1: to blame? Is it the benzo? Is it the opioid? Yeah?
- 28:04Speaker 1: You know, if you have a school yard. Yeah, if
- 28:06Speaker 1: Johnny insults Freddy and dares Frey to punch him, and
- 28:08Speaker 1: Freddy punches Johnny, who gets after school attention? Typically both, right,
- 28:14Speaker 1: but not always. You know, in healthcare, it's a patient
- 28:17Speaker 1: utilizes an opiod in the benzo and then there's an
- 28:19Speaker 1: overdose with rest per depression, which medications that fault. That's
- 28:22Speaker 1: where we get those related deaths where the opiod and
- 28:24Speaker 1: the benzo would both be related in there as well too.
- 28:28Speaker 1: All right, so you know this overdose talk, what about
- 28:30Speaker 1: benzo overdose? What do we do? Who we gonna call?
- 28:33Speaker 1: We're gonna call L masonill. It's actually a gabba a
- 28:37Speaker 1: antagonist of course, iv or even in toernasal these days,
- 28:42Speaker 1: that's there, you know, to come to the rescue. It's
- 28:44Speaker 1: an antagonist. It blocks the GABBA receptors. So luckily, if
- 28:48Speaker 1: there's too much benzo, we have that around. It's actually
- 28:51Speaker 1: been around for decades now, back in the eighties, I
- 28:54Speaker 1: think it was FDA PREW back in the nineties, nineteen
- 28:57Speaker 1: ninety one available generic of course too. That being said,
- 29:02Speaker 1: kind of other side the coin uh, and kind of
- 29:04Speaker 1: wrapping up here as far as benzos within Thug Drugs,
- 29:07Speaker 1: Gaba Gabba Gabba benzos, you know, we just talked about
- 29:11Speaker 1: all the negative sides. Well, benzos are commonly utilized in
- 29:13Speaker 1: drug overdose treatment overall. You know, we have things like
- 29:16Speaker 1: propofol and dasa lamb and the rais of PAM that
- 29:19Speaker 1: are often used, you know, to help in the scenario
- 29:22Speaker 1: of folks overdosing on other substances. Right, you know, common
- 29:27Speaker 1: things now and overall, so you know, it's it's uh gosh.
- 29:31Speaker 1: I usually say this for methadone, but Charles dickens the
- 29:34Speaker 1: best of times, the worst of times. But in the
- 29:37Speaker 1: end we're talking about all the maters, the tomatoes, right,
- 29:41Speaker 1: So hopefully, Hey, this is a podcast, folks, not a class.
- 29:45Speaker 1: This relatively rapid rundown of Gabba Gabba Gabba, the Thug
- 29:48Speaker 1: Drugs miniseries. Here in the Pain Pod as we covered kayludes,
- 29:53Speaker 1: methic way, loan, fenebat GHB, barbituous, Gabba, petenoids, benzos. It's
- 29:58Speaker 1: all about the tomatoes. Hey, they all because Gaba is
- 30:01Speaker 1: in there too. But folks, as always, it's all about
- 30:04Speaker 1: the dosage. Paracelsus paraphrase from his Latin though solo doses
- 30:09Speaker 1: fast vendum. We're not gonna worry about the tomatoes, but
- 30:11Speaker 1: we're gonna worry about the substances we talked about today,
- 30:14Speaker 1: the Gabba effects within that ballpark of NeuRA one and
- 30:18Speaker 1: Aron two pre snaptic post snapping, and it collapped in between.
- 30:22Speaker 1: So I hope this was a beneficial rundown of all
- 30:25Speaker 1: things Gaba here. I certainly hope you enjoyed this episode
- 30:28Speaker 1: of the Pain Pod with our miniseeries of thug drugs. Gaba, Gaba, Gabba.
- 30:33Speaker 1: Till the next time, folks, I wish you a great
- 30:35Speaker 1: day every day.
- 30:38Speaker 2: If you'd like to join Mark on the Pain Pod,
- 30:41Speaker 2: send us an email to publish You're at Pharmacy podcast
- 30:45Speaker 2: dot com, and make sure to share the show and
- 30:48Speaker 2: subscribe on your favorite podcast directory.
- 30:52Speaker 1: Thanks for listening.